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Science Center, Houston, TexasABSTRACT The N-methyl-D-aspartate receptor (NMDAR) is a member of the glutamate receptor family of proteins and is
responsible for excitatory transmission. Activation of the receptor is thought to be controlled by conformational changes in
the ligand binding domain (LBD); however, glutamate receptor LBDs can occupy multiple conformations even in the activated
form. This work probes equilibrium transitions among NMDAR LBD conformations by monitoring the distance across the glycine-
bound LBD cleft using single-molecule Fo¨rster resonance energy transfer (smFRET). Recent improvements in photoprotection
solutions allowed us to monitor transitions among the multiple conformations. Also, we applied a recently developed model-free
algorithm called ‘‘step transition and state identification’’ to identify the number of states, their smFRET efficiencies, and their
interstate kinetics. Reversible interstate conversions, corresponding to transitions among a wide range of cleft widths, were iden-
tified in the glycine-bound LBD, on much longer timescales compared to channel opening. These transitions were confirmed to
be equilibrium in nature by shifting the distribution reversibly via denaturant. We found that the NMDAR LBD proceeds primarily
from one adjacent smFRET state to the next under equilibrium conditions, consistent with a cleft-opening/closing mechanism.
Overall, by analyzing the state-to-state transition dynamics and distributions, we achieve insight into specifics of long-lived LBD
equilibrium structural dynamics, as well as obtain a more general description of equilibrium folding/unfolding in a conformation-
ally dynamic protein. The relationship between such long-lived LBD dynamics and channel function in the full receptor remains
an open and interesting question.INTRODUCTIONThe N-methyl-D-aspartate receptor (NMDAR) is a member
of the glutamate receptor family of proteins, along with the
AMPA receptor and the kainate receptor. These receptors
mediate ion transport in the cellular membrane and are
considered potential drug targets for treatment of a number
of neurological diseases including Alzheimer’s and Parkin-
son’s (1–6). The NMDAR is unique among the glutamate
receptors in that it forms hetero-tetrameric complexes using
two glycine-binding GluN1 subunits, and two other sub-
units, either the glutamate-binding subunit GluN2 or the
glycine-binding GluN3 subunit (7–16). Each subunit com-
prises four main domains—the extracellular N-terminal
domain, the ligand-binding domain (LBD), the intracel-
lular C-terminal domain, and the transmembrane domain
(14–19). The LBD cleft, comprised of two lobes connected
by a hinge, is responsible for inducing large conformational
changes that control the opening and closing of the cation
channel, allowing for the regulation of ion concentration
into the cell (19–29). Agonist binding induces a closing ofSubmitted August 8, 2014, and accepted for publication May 18, 2015.
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0006-3495/15/07/0066/10 $2.00the LBD cleft (see Fig. 1, inset) (24,25), which in turn opens
the ion channel in the full-length protein (24–34). The
average distance of the isolated LBD cleft closure has
been shown to directly correlate to channel transport effi-
ciency for multiple glutamate receptor types (18,35–37), al-
lowing the isolated LBD to be used as a model for further
conformational analysis and prediction of channel transport
efficiencies.
The NMDAR has a lower conformational stability and
a higher range of conformations than the other glutamate
receptors, including reported structure/function fluctua-
tions with time constants as long as seconds (7,31–34).
This increased instability likely plays a key role in the
functionality of the NMDAR (24–29). Simulations of
the NMDAR LBD suggest that the energy landscape of
the protein is broad, even when bound to the primary
agonist, indicating that there are many conformations that
are weakly stable (19,38). In addition to the conformational
changes experienced during normal receptor function, the
protein can also unfold due to loss of stability of the folded
state (18,39,40). Traditionally, structural determination
through crystallographic methods has allowed for a detailed
picture of only the most stable conformation to be obtained
(15–17,38,41). Such information is static and must be paired
with electrophysiological measurements to correlate currenthttp://dx.doi.org/10.1016/j.bpj.2015.05.025
NMDAR Conformational State Transitions 67flow through the channel with static conformations. Due to
the complex nature of protein folding, it is believed that the
folding energy landscape contains a number of partially
stable conformational states and that these energy minima
help explain how proteins can fold into nonnative states
(42,43). However, a link between the theory of broad
conformational distributions and experimental studies of
equilibrium transitions among conformations is lacking.
Single-molecule Fo¨rster resonance energy transfer
(smFRET) experiments allow us to probe protein folding/
unfolding dynamics on millisecond to second timescales
(35,44–47). By collecting a statistically meaningful distri-
bution of smFRET time trajectories, the entire ensemble
equilibrium smFRET distribution, and therefore a detailed
understanding of equilibrium dynamics, can be acquired
(20,34–38,46). Here, we apply smFRET to record the
dynamics occurring in the LBD cleft (Fig. 1), under satu-
rating glycine conditions. At the high concentrations of
glycine used in our experiments, the binding rate constant
is ~8 ms1 (48), which is much faster than our collection
rate of 1 ms1. Therefore, any unbinding event is associated
with a corresponding binding event faster than our time
resolution, and we instead observe equilibrium transitions
among the many conformations that comprise the time-aver-
aged glycine-bound LBD state.
To our knowledge, our results provide several new in-
sights. First, the resulting smFRET distribution for the
NMDAR LBD correlates well to the derived energy land-
scape seen in simulation studies of the glycine-bound
NMDAR LBD (38,49), which, along with another recent
smFRET study (37), supports the conclusion that we are
indeed monitoring LBD cleft conformational states. More
importantly, we introduce a model-free step transition and
state identification method (STaSI) to identify additional
cleft states in the isolated LBD that are too wide to be
observed in the full hetero-tetramer. Using STaSI and recent
advances in extending smFRET trajectories (50–53), transi-
tion analysis confirms that interstate conversions follow
equilibrium statistics. Although it is unclear how these
long-lived states relate to channel function in the full
receptor, the states identified by smFRET correlate well to
the broad distribution of states identified in umbrella sam-
pling models of the LBD cleft in both NMDA and AMPA
receptors (38,54). In addition, it is possible with both the
AMPAR and NMDAR LBDs to relate average smFRET
values for a variety of agonist conditions to agonist binding
strength and macroscale ion transport across the channel
(35–37).
To further test the hypothesis that the observed transitions
represent equilibrium dynamics across the LBD cleft, guani-
dinium chloride (GdmCl) was used to shift the distribution
of identified states toward more open, and upon reversal,
more closed forms. Although it is unknown whether such
denaturants as GdmCl and urea induce protein denaturation
through the normal folding pathway or via alternate energywells (42), it is nonetheless useful to demonstrate that the
broad distribution of states identified for the NMDA LBD
can be reversibly shifted using such methods. Due to both
experimental and computational limitations, most protein
folding dynamics studies focus on sub-millisecond time-
scales (55,56), thus we hope the studies presented here
also provide guidance on how to combine denaturants
with smFRET to understand folding dynamics that occur
on longer timescales. Overall, the observed transition statis-
tics provide insight into the relationship between conforma-
tional dynamics and function in the NMDAR LBD as well
as providing mechanistic detail about the more general topic
of protein-folding/unfolding dynamics.MATERIALS AND METHODS
Protein preparation
A pet22B vector encoding N-terminal His-tagged NMDAR GluN1 isolated
ligand-binding domain was provided by Eric Gouaux (Oregon Health and
Science University, Portland, OR). Serine 115, located at the end of helix
C in domain 1, and Threonine 193, located in the middle of helix G in
domain 2 (S507 and T701 in the full-length protein), were mutated to
cysteines using standard polymerase chain reaction methods with PfuTurbo
DNA polymerase AD (Agilent Technologies, Santa Clara, CA) and primers
obtained from Sigma-Aldrich (St. Louis, MO). These plasmids were
then transformed into Origami B (DE3) Escherichia coli (Novagen, Darm-
stadt, Germany) and plated onto LB Agar (Thermo Fisher Scientific,
Waltham, MA) supplemented with 50 mg/mL ampicillin (Sigma-Aldrich),
15 mg/mL kanamycin (Thermo Fisher Scientific), and 12.5 mg/mL tetracy-
cline (Calbiochem, San Diego, CA). Isolated colonies were grown at 37C
in liquid Miller’s Luria Broth (Thermo Fisher Scientific), and protein pro-
duction was induced when the culture reached an OD600 of 0.8.
To induce protein production, IPTG (isopropyl b-D-1-thiogalactopyrano-
side; Thermo Fisher Scientific) was added to a final concentration of
0.5 mM. For unnatural amino acid (UnAA) experiments, S115 and T193
were mutated to the amber stop codon, TAG, while the original stop codon
was mutated from amber to ochre, TAA (37). The machinery to incorporate
the UnAA was included by cotransforming the Origami E. coli with the
pEVOL plasmid obtained from Peter Schultz (The Scripps Research Insti-
tute, San Diego, CA) (57). The pEVOL plasmid contains the UnAA
p-acetyl-L-phenylalanine tRNA synthetase developed from the Methano-
coccus jansaschii TyrRS, as well as the suppressor tRNACUA. Nonspecific
read-through of the amber stop codon by natural amino acids, while
possible, would result in protein that would not be labeled with a FRET
pair and would thus be invisible to our experiments. The pEVOL plasmid
was maintained using 50 mg/mL chloramphenicol (Acros Organics, Geel,
Belgium). For these experiments 0.02% arabinose (Sigma-Aldrich) and
1 mM p-acetyl-L-phenylalanine (RSP Amino Acids, Shirley, MA) was
added in addition to IPTG. The E. coli were then allowed to grow for
24 h at 20C before pelleting the cultures down and storing at 80C.
The UnAA NMDAR was analyzed by mass spectrometry to ensure proper
expression (see Table S1 in the Supporting Material).
On the day before scanning, the pellets were thawed and lysed using a
cell disruption vessel (Parr Instruments, Moline, IL). Cell debris was pel-
leted at 40,000 rpm for 1 h at 4C, and the supernatant was further filtered
through a 0.45-mm nylon membrane (Thermo Fisher Scientific). This
filtrate was then purified via fast protein liquid chromatography (A˚KTA,
Chicago, IL) using a linear imidazole gradient (Buffer A: 200 mM NaCl,
20 mM Tris, 1 mM glycine, pH 8.0; Buffer B: 200 mM NaCl, 20 mM
Tris, 1 mM glycine, 400 mM imidazole, pH 8.0), and a HiTrap Chelating
column (GE Lifesciences, Pitsburgh, PA) that had been charged withBiophysical Journal 109(1) 66–75
68 Cooper et al.NiSO4 (Mallinckrodt Pharmaceuticals, Dublin, Ireland). Purified protein
was then dialyzed for 2 h in PBS (phosphate-buffered saline) supplemented
with 1 mM glycine (Thermo Fisher Scientific).Protein labeling
On the day of scanning, dialyzed protein was quantified and labeled with
Alexa 555 and Alexa 647 maleimide (Invitrogen, Grand Island, NY) to
label cysteines, or the hydrazide versions of the dyes for the UnAA exper-
iments. Dye was added to give a 1:1:4 protein/Alexa555/Alexa647. After a
30-min labeling time, protein was separated from unreacted fluorophores
using a PD-10 desalting column (GE Healthcare Lifesciences). After this,
protein was then further dialyzed in PBS with 1 mM glycine for 30 min.
After dialysis, protein was then incubated with SulfoLink resin (Thermo
Fisher Scientific) for another 30 min. Finally, 1 mg of biotin-conjugated
anti-His epitope antibody (Rockland Immunochemicals, Limerick, PA)
was added to 500 mL of the prepared protein.Anisotropy measurements
Polarization anisotropy measurements were performed on the cysteine-
labeled NMDAR LBD using an OD470 single-photon counting spectrom-
eter (Edinburgh Instruments, Livingston, UK). A 657.2-nm excitation,
200-ns pulsed laser beam was emitted by a picosecond pulse diode laser
(Edinburgh Instruments) and photons were collected at 675 nm. Four decay
curves were recorded comprising horizontal and vertical detection polariza-
tions after excitation in both the horizontal and vertical directions. The
anisotropy curve was calculated from the decay curves and shown in
Fig. S1 in the Supporting Material.Microscope setup
All single-molecule fluorescence measurements were performed using a
custom-built confocal microscope described previously in Landes et al.
(35) and Darugar et al. (46). Briefly, the sample was excited with a contin-
uous-wave 532-nm laser (Compass 315M-100 SL; Coherent, Santa Clara,
CA) and focused through an oil immersion 100 1.3 NA objective lens
(Carl Zeiss, Oberkochen, Germany) onto the sample with a power density
of ~50 W/cm2 at the sample. The sample position was controlled with a
scanning x-y-z piezo stage (P-517.3CL; Physik Instrumente, Karlsruhe,
Germany) and the sample was moved to focus the confocal spot onto single
molecules. Emitted light was collected back through the same objective and
separated with a 640-nm high-pass dichroic mirror (640 DCXR; Chroma
Technology, Bellows Falls, VT), then collected by two avalanche photodi-
odes (SPCM-AQR-15; PerkinElmer, Waltham, MA) tuned to 570 and
670 nm with band-pass filters (NHPF-532.0; Kaiser Optical Systems,
Ann Arbor, MI and ET585; Chroma Technology) for donor and acceptor
signal collection, respectively.Sample chamber preparation
A sample chamber was prepared similar to that described previously in
single-molecule measurements with the glutamate receptors (35,36).
Plasma-cleaned 22 22 mmNo. 1 glass coverslips were treated with a Vec-
tabond-acetone solution (1% wt/vol; Vector Laboratories, Burlingame, CA)
and stored under vacuum. Using silicone templates, a small section of the
Vectabond-treated slides were then covered with a mixture containing
5 kDa biotin-terminated PEG (polyethylene glycol 2.5% w/w in MB water;
NOF, Burlingame, CA) and sodium bicarbonate (Sigma-Aldrich) and
allowed to dry in the dark for 4–6 h. Excess PEG was washed off and the
pegylated area was covered with a custom 13-mL HybriWell chamber
(Grace Bio-Labs, Bend, OR) fitted with two press fit silicon ports (Grace
Bio-Labs) for entry and outlet flow tubes before taking a control imageBiophysical Journal 109(1) 66–75of the pegylated slide with PBS buffer. A solution of 0.2 mg/mL streptavi-
din (Invitrogen) in PBS buffer was added to the chamber and incubated for
10 min. Approximately 60 mL of 20 nM protein was added to the chamber
in three successive injections and incubated for 20 min before being flushed
with excess buffer solution and the sample was placed on the piezo stage for
binding conformation.Flow system preparation
To prolong photobleaching lifetimes, all experiments were performed in the
presence of an oxygen-scavenging buffer system, consisting of 33% w/w
b-D-(þ)-glucose, 1% w/w glucose oxidase, 0.1% v/v catalase, 1 mM
methyl viologen, and 1 mM ascorbic acid (all from Sigma-Aldrich) in
MB water (MB Water Technologies, Chennai, India) saturated with phos-
phate buffer (50,52). In addition, 1 mM of glycine was added to the oxy-
gen-scavenging system, depending on the experimental conditions. This
solution was continuously pumped through the chamber at a rate of 1
mL/min. In all of the denaturant studies an additional flow system was set
up containing 8 M guanidinium chloride (Sigma-Aldrich) and 1 mM
glycine. For our measurements, the mean lifetime of the protein during
observation was 4.96 s, assuming a first-order exponential decay process
for photobleaching (see Fig. S2). Concentration of denaturant in the cham-
ber was controlled by varying the flow rate in combination with the oxygen-
scavenging system flow to get the desired concentration from the final
mixed flow. For the single-molecule denaturant study the system was
allowed to equilibrate for 30 min before data collection.Single-molecule data collection
To obtain smFRET trajectories for the individual protein molecules, a 10 
10 mm area of the sample was scanned to spatially locate 20–25 molecules.
Once a molecule had been located, the stagewas moved to place it under the
laser focus, and the fluorescence signals of the donor and the acceptor were
collected until the fluorophores were photobleached. The emission intensity
trajectories were collected at 1-ms resolution and later binned to 10-ms time
steps to improve signal/noise. Example trajectories are shown with the
collected photon counts for the acceptor and donor channel (see Fig. 4, a
and d) used to calculate the observed and denoised FRET signals (see
Fig. 4, b and e).Denaturation experiments
For the denaturation experiments, an area of 30  30 mm was raster-
scanned three times and its location was recorded. Power of the laser was
set to ~25 W/cm2 at the sample and the speed of the scan was set to
1000 pixels per s with 256 pixels per line and 256 lines per image for a final
per image time of 65.7 s. After the area image had been collected, the flow
was adjusted to a new concentration of denaturant and left for 20 min to
equilibrate, after which the area was rescanned under the new denaturant
conditions. This process built up a series of images of the same molecules
under all conditions of denaturant.Data processing
All data was analyzed with programs written in-house using the software
MATLAB (R2009b; The MathWorks, Natick, MA). The signal was pro-
cessed via the wavelet denoising technique and the FRET efficiency was
calculated from the denoised signal using the Fo¨rster equation (58). Wavelet
denoising should not change the identification of the states, as verified by
simulation (Fig. S3). A postprocessing algorithm was used to characterize
the trajectories and ensure that they matched the criteria for a single-mole-
cule, single-FRET-pair signal. Of the 238 trajectories collected, 76 were
excluded after meeting the conditions of multistep bleaching or abnormally
NMDAR Conformational State Transitions 69high background noise based on a normal distribution leaving 162 single-
donor and single-acceptor-labeled molecules (59).
The raster-scanned area images were also analyzed with MATLAB. Each
area was averaged with its repeats to enhance signal/noise. Molecules were
located in the acceptor channel via a cutoff value set at the maximum inten-
sity of the control image and grouped according to a Gaussian fitting to
exclude clusters and single pixels of bright noise. The areas were spatially
corrected to account for drift in the sample over the duration of the exper-
iment. The FRET signal for each molecule was obtained and tracked
throughout the experiment to build a denaturation profile of the protein.FIGURE 1 Measured ensemble smFRET distribution for the NMDAR
LBD with glycine bound. (Dashed curves) Gaussian fits for each state;
(solid magenta curve) total sum of Gaussians to provide a visual estimate
for the goodness of fits of the seven-state model. (Inset) Structure of the
NMDAR GluN1 isolated LBD bound to glycine, based on the PDB:1PB7
crystal structure. The protein strand was mutated at T193 (red marker)
and S115 (blue marker) to cysteine to attach the acceptor and donor fluoro-
phores. A His-tag was added to the protein at the N-terminus (yellow
marker) to allow for immobilization. (Green-dashed line) FRET distance,
which changes as the protein opens and closes the cleft.Step transition and state identification analysis
The step-transition-and-state-identification (STaSI) method was developed
to help cluster FRET traces into the optimum number of states with minimal
user input (51), as opposed to other methods such as hidden Markov
modeling or change point analysis, which require either foreknowledge
of the number of expected states or the data to be raw-time-tagged rather
than binned (60–62). STaSI combines the advantages of the bias-free
approach of an information theoretic analysis method with the ability to
analyze binned data to allow for unbiased conformational state determina-
tion. STaSI first identifies all the transition points using Student’s t-test (see
Eq. S1 in the Supporting Material) based on similar analysis used in single-
photon counting experiments (62,63). These identified transition points
break down the FRET trace into different segments, and the t-test is applied
to each segment until no further transition points are identified. After that, a
hierarchical clustering is applied on the segments. For each clustering level,
the difference between every remaining two-segment pairing is measured
by its merit of likelihood (see Eq. S2 in the Supporting Material). The
two clustered segments corresponding to the lowest difference are grouped
into a single state and treated as a singular cluster in the next iteration. This
process is repeated until the entire data-set is in a single state. We then
applied the minimum description length (MDL) equation (see Eq. S3 in
the Supporting Material) to the data set for each state assignment set and
determined the optimum number of states. The MDL equation considers
both the goodness of fit and the complexity of the fitting model. Simulation
tests show MDL avoids overfitting and underfitting even with high noise
level (51). More detailed explanation of STaSI can be found in the Support-
ing Material.RESULTS AND DISCUSSION
We collected 162 molecules over five samples of the iso-
lated NMDAR LBD under conditions of saturating glycine.
The FRET efficiencies of the single molecules were
combined to produce the distribution shown in Fig. 1. The
highest probability FRET value in the ensemble smFRET
distribution is ~0.95. This value corresponds to a cross-cleft
distance of 3.2 nm, correlating well with the 3.4-nm cross-
cleft distance calculated from the crystal structure for the
glycine-bound LBD (PDB:1PB7; Protein Data Bank,
www.wwpdb.org) observed in static structural analyses
(24). The overall smFRET distribution, however, is very
broad, indicating a wide variety of different conformations
in addition to the most probable conformation. In fact,
some smFRET values (e.g., those <~0.60) represent such
open conformations that they would not be observable in
the full heterodimer construct due to steric hindrance, but
are possible in the isolated LBD. The small amounts of
protein exhibiting FRET efficiency values >1 are due to
the background correction using the average value resultingin noise bringing the donor signal to <0 before FRET effi-
ciency is calculated.
The FRETefficiency distribution in Fig. 1 is best described
by seven underlying states (Fig. 2). The seven states are
located at FRET efficiency values of 0.96, 0.87, 0.79, 0.68,
0.53, 0.43, and 0.28 (Table 1). To determine the number, loca-
tion, and state-to-state transition points, we first reduced the
noise of each smFRET trajectory with the wavelet denoising
method (58,59), then analyzed the trajectories using the
STaSI method (51), which was specifically developed to
workwith binned smFRET data (details are explained inMa-
terials and Methods and in the Supporting Material). Based
on state determination methods for single-photon counting
and the MDL principle (62,63), STaSI was tested for validity
with simulated trajectories with similar levels of noise to our
data (see Fig. S4). Individually, each of the identified states
has a relatively tight distribution, with a FRET efficiency
standard deviation of50.04 on average, which is consistent
with our measured noise level.
A comparison of the FRET response from a modified
version of the NMDAR LBD containing an alternate label-
ing scheme shows that the FRET response is independent ofBiophysical Journal 109(1) 66–75
FIGURE 2 The STaSI method determines the
number and location of the states based on the
denoised data. (a) All of the denoised smFRET tra-
jectories were combined after local background
subtraction and blink filtering, to provide a suffi-
ciently large basis for the STaSI method to accu-
rately locate the states, a 100 downsampled
portion of which is shown. (b) The percentage as-
signed to each state from the total data set. FRET
efficiency can be tracked horizontally from the
data trajectory to the histogram. The contour of
the distribution reflects the distribution of the
measured FRET efficiency in Fig. 1.
70 Cooper et al.labeling strategy and only occurs under normal labeling
conditions (see Fig. S5). This is an important control
because the traditional fluorescence labeling strategy binds
the maleimide construct of the desired fluorophores to the
sulfur atom of a point-mutated cysteine residue. However,
inside the NMDAR LBD there exist native cysteine residues
that cannot be mutated out, introducing potential alternate
binding sites in the protein. The control involved an alterna-
tive method of dye attachment recently introduced by
Dolino et al. (37) and Young et al. (57), which uses
UnAA-containing functional groups not found in the stan-
dard 20 eukaryote amino acids to elicit greater binding
site specificity. By point-mutating an UnAA at the desired
labeling site, it is possible to have much higher specificity
for fluorescence labeling. We used STaSI to compare the
data from the ketone UnAA construct of the NMDAR
LBD in glycine-saturated conditions to the data obtained
from the cysteine-mutation-labeled NMDAR LBD (see
Fig. S6) (37). STaSI analysis of both systems suggests seven
states that match very closely to each other within the mea-
surements and extraction errors (Table 1). Furthermore, to
ensure that rotational hindrance caused by the attachment
of the dyes to the protein did not affect the smFRET results,
we used time-resolved rotational anisotropy to measure the
rotational correlation time. The cysteine-labeled NMDAR
LBD had a correlation relaxation time of 0.34 ns, indicating
that the dye had sufficient rotational freedom to justify the
use of 2/3 for the orientation factor in the FRET calculation
(see Fig. S1) (64). These controls show that the contribution
of the labeling scheme to the breadth of the smFRET distri-
bution is minimal.
In order to show that the range of FRET efficiencies is
related to conformation shift, we performed a denaturant
assay to shift the state distribution. Upon the addition of
the denaturant GdmCl to the NMDAR LBD solution, the
average FRET efficiency decreases linearly with increasingTABLE 1 Summary of the states found for both the cysteine-labele
Cysteine states FRET efficiency 0.965 0.03 0.875 0.03 0.795
Cysteine state (%) 27.0 21.6 15.6
UnAA states FRET efficiency 0.985 0.03 0.905 0.04 0.815
UnAA state (%) 31.1 23.9 18.7
Biophysical Journal 109(1) 66–75concentration of GdmCl (Fig. 3). This shift is much more
apparent when the average FRET values of all the molecules
are plotted against the concentration of GdmCl (Fig. 3 b).
Additionally, the shift toward lower FRET efficiencies in
the presence of denaturant is reversible when denaturant
concentration is lowered, as seen when the average values
are replotted as a function of experimental time (Fig. 3 c).
This effect is seen more clearly in the single-molecule tra-
jectories taken for molecules before exposure to denaturant,
during high concentrations of denaturant, and after dena-
turant concentration had been lowered (Fig. S7). The rebuilt
ensemble distributions show a loss of the high FRET effi-
ciency states in the presence of GdmCl, but the original state
distribution is recovered after the denaturant is washed out,
demonstrating that the conformation shift is a reversible
process.
Due to the low signal/background intrinsic to the image
analysis method (as compared to trajectory analysis),
some populations of molecules are identified as having a
FRET efficiency value of 1 or 0, because at these positions
either the donor signal or the acceptor signal was indistin-
guishable from the background (Fig. 3 a). For statistical rea-
sons, these values are not removed from the histograms, but
do not reflect any physically meaningful structural informa-
tion. Besides the effects of the denaturant concentration,
there is an apparent drop in calculated FRET efficiency
values occurring from the time-dependent photobleaching
of the acceptor dye for labeled protein molecules. This ex-
plains why, at the two final concentrations, the average
FRET values return to a slightly lower FRET efficiency
than would be predicted. Regardless, the overall trend is
consistent, namely that the population of lower FRET states
correlates well with denaturant.
A broader explanation for the wide range of FRET values
is that they reflect the equilibrium folding/unfolding land-
scape of the NMDAR LBD. The exact physical cause ofd NMDAR LBD and the UnAA-labeled NMDAR LBD
0.03 0.685 0.05 0.535 0.05 0.435 0.05 0.285 0.04
13.7 12.3 6.0 3.8
0.04 0.655 0.05 0.535 0.05 0.435 0.05 0.215 0.03
6.2 5.5 12.0 2.7
FIGURE 3 Low-resolution raster-scanned image analysis shows how the
average smFRET value from a single population of NMDAR LBD proteins
changes as a function of GdmCl concentration. (a) A shift from high FRET
efficiency to low FRET efficiency as denaturant concentration is increased
can be seen in the histograms for the calculated FRET efficiency for iden-
tified molecules under each condition. (b) Combined average FRET effi-
ciency for all of the areas as a function of GdmCl concentration. (c)
Replotting the calculated average FRET efficiency against time elapsed
for the denaturation experiment shows that by lowering the denaturant con-
centration the protein was able to recover, and that the denaturant’s effect on
the NMDAR LBD is a reversible process; however, time-dependent photo-
bleaching of the acceptor dye is also observed. The error bars plotted repre-
sent the distribution in the average among the different areas.
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debate, but by exploring the interactions of the states with
one another from the single-molecule trajectories, and by
observing the shift in the conformational distribution as a
function of denaturant, we can begin to get insight into
the broader topic of protein conformation dynamics, not
just for the NMDAR LBD. The remainder of this work rep-
resents an effort to establish a relationship between the con-
formations of the NMDAR LBD in particular as related to
ion-channel protein function, as well as the more general
topic of equilibrium protein folding/unfolding, based on
an analysis of interstate equilibrium dynamics.
The seven states can be generally grouped into either high
FRET efficiency or low FRET efficiency regions. The four
states with high FRET efficiency (0.96, 0.87, 0.79, and
0.68; corresponding to intercleft distances of 3.0, 3.7, 4.1,
and 4.5 nm, respectively) can be further divided into two
categories: the 0.96 and 0.87 FRET efficiencies, which
correspond to closed-cleft conditions (24); and the 0.79and 0.68 FRET efficiencies, which are associated with
more open conformations. The division for these assign-
ments is based on the known crystal structure of the closed
cleft agonist-bound form (PDB:1PB7) and the open cleft
antagonist-bound NMDAR LBD (PDB:1PBQ), the former
of which shows a cleft distance of 3.4 nm and the latter of
which shows cleft distances of 3.9–4.0 nm (24).
The states with low FRET efficiencies (0.53, 0.43, and
0.28; corresponding to distance of 5.0, 5.3, and 5.9 nm,
respectively) indicate that the protein can visit unexpected
conformations that are more open than any values observed
in the full receptor for bulk ensemble studies and are expected
not to be present in a functional full-length receptor. Based on
the glycine-bound crystal structure (24), the furthest attain-
able distance for any type of motion of the LBD, and thus
the maximum possible distance between the two dye attach-
ment sites, is ~5.0 nm. Thus, further opening of theLBD frag-
ment may be due to the lack of steric hindrance experienced
by the isolated LBD structure used in these experiments as
compared to the spatially constrained LBD in the mem-
brane-imbedded tetramer, and could also include partial un-
folding. In the full-length NMDAR, neighboring segments of
the tetrameric structure limit the possible distance achievable
for any motion of the LBD >~5 nm (15,16). Thus, although
open conformational states of the agonist-bound LBD are
predicted from the theory, in our smFRET studies the cleft
can explore even more extreme conformations than would
exist in the full-length protein.
There are 145 smFRET trajectories (86% of the traces;
80% of the data points) that occupy only one or two states,
and therefore only contain a few transitions (Fig. 4, a–c). Of
these, 78 trajectories (46% of the traces; 37% of the data
points) display only a single state for the duration of obser-
vation. Due to the stochastic nature of photobleaching,
many of these trajectories are shorter than the mean lifetime
of observation, and hence do not fluoresce long enough to
visit multiple states. These trajectories do not contribute to
the transition analysis but are still valuable in recreating
the overall conformational landscape. Furthermore, each
of the seven STaSI-identified states is well represented
within the individual static trajectories.
The remaining 24 trajectories (14% of the traces; 20% of
the data points) exhibit reversible interstate dynamics
(Fig. 4, d–f). The protein not only transitions back and forth
between two different states, but also remains stable in both
states for hundreds of milliseconds at a time, before revert-
ing again. This reversible transition suggests that the protein
is actively exploring alternate conformations and that the
protein is unlikely to be simply degrading and/or completely
unfolding. The reversible nature of these trajectories indi-
cates that all of the visited states lie in equilibrium with
each other, and represent real conformational states that
the LBD experiences.
Our method is unable to comment on dynamics faster
than could be detected by the 1-ms bin time of ourBiophysical Journal 109(1) 66–75
FIGURE 4 Two example single-molecule trajectories with the calculated FRET efficiency and state distribution. (a and d) The acceptor and donor signal
for a single identified NMDAR LBD. The signal has been background-corrected and blink-filtered and shows a strong anticorrelation between the donor and
acceptor, which is indicative of smFRET. (b and e) The corresponding apparent FRET efficiency for the signal in (a) and (d), respectively. The STaSI state at
each time point is overlaid. (c and f) The smFRET histogram for each individual trajectory. The STaSI state histogram has also been overlaid and rescaled so
that the maximum peak is the same height as the denoised maximum. (a–c) Example protein that remained stable in a high FRET efficiency state before
transitioning into a stable lower FRET efficiency state and thus a more open-cleft conformation. (d–f) State-to-state movement is not one-directional and
the NMDAR LBD can recover into the original state after visiting the open-cleft conformation.
FIGURE 5 Matrix of transition counts between the STaSI states. The
state of the protein before the transition point defines the vertical axis,
and the state that the NMDAR LBD transitions to is the horizontal axis.
State transitions cannot occur between a state and itself, which nullifies
the diagonal. (Color) Total number of transitions for that state pair.
72 Cooper et al.collection. However, for the ranges presented, there is good
agreement with the ion channel studies for the NMDAR
LBD (27–29). The apparent semistable states that exist
near the distance corresponding with ion channel activation
could be responsible for the inability of the NMDAR to acti-
vate unless all four subunits of the full tetramer act together.
Further work is needed to observe the effects that alternate
agonists have on the conformational landscape of the
NMDAR.
The number of transitions from each state to every other
state was extracted from the smFRET time trajectories, and
their transition pattern is consistent with the previous theo-
retical predictions (Fig. 5) (38,49). The transition counts in
Fig. 5 show that the major transitions happen primarily be-
tween adjacent states, represented by the warm colors of the
transitions along the diagonal. As the analysis describes mo-
tions between states that are further away from each other,
the number of observed transitions decays quickly. Given
that the positional placement of the acceptor and donor
attachment sites are on opposite sides of the cleft, adjacent
FRET states, also being adjacent conformational states, sug-
gest that the observed motion is an ordered opening and
closing of the cleft. This property agrees well with predicted
models of the NMDAR LBD dynamics published by YaoBiophysical Journal 109(1) 66–75et al. (38), who postulated that the protein moves along a
well-ordered opening pathway between adjacent conforma-
tions. This also agrees well with the predicted clam-shell
model often used to describe the motion of the glutamate
receptor LBDs (35).
NMDAR Conformational State Transitions 73The transitions have a high degree of symmetry across the
diagonal in Fig. 5, indicating that the protein is undergoing
equilibrium transitions, even among the lowest FRET states.
These reversible transitions suggest that the low FRET effi-
ciency states are indeed metastable states within the folding/
unfolding equilibrium. Nonequilibrium unfolding, due to
either unfavorable mutations or the immobilization process,
could also cause transitions between FRET states to occur
but would not be reversible processes. Thus, the data is
strongly suggestive of interconversions among a broad
range of conformations that reflect both those that would
occur in the native, membrane-imbedded NMDAR and
transitions to more open states within the underlying highly
dynamic LBD that are otherwise constricted in the full het-
erodimer construct. Buried within the broad range of confor-
mations, however, is information about the conformational
flexibility within the ligand-bound form, the possible path-
ways for functional activation, and insight into reversible
protein folding/unfolding (19,35,36,38).
Because we observe such a wide range of reversible tran-
sitions, and because conformational flexibility is a required
hallmark of activation within the full NMDAR heterodimer
(13), the observed transitions within isolated single
NMDAR LBDs could give some insight into the activation
process. Based on crystal structures, it has been hypothe-
sized that the cleft-closure conformational change is the
primary mediator of activation. In fact, among all of the
possible interstate transitions, the most probable occurs be-
tween 0.87 and 0.79 FRET efficiencies (Fig. 5), just at the
break between the two closed-cleft FRET states and the
two open-cleft FRET states. The distance of the open-cleft
conformation of the LBD from crystal structure is just above
0.82 FRET efficiency (24). Thus, it is interesting to observe
that the most probable observed transition corresponds to
the distance at which a cleft-closure conformational change
would result in an active channel. Further experiments and
theoretical modeling would provide more direction as to
how the varying smFRET states could be of value in under-
standing the cleft-closure mechanism.
The origin of the transitions among the states with
FRET <0.60, however, is not clearly relatable to function
in the full membrane-imbedded receptor, but still provides
valuable insight into the reversible folding/unfolding at a
few key points of the cleft, as mentioned earlier. The shifting
of the equilibrium of the FRET values to the lower states
during high concentration of GdmCl indicates that the lower
states may be associated with partial unfolding of the pro-
tein. GdmCl should weaken the bonds in the backbone
structure of the protein, increasing its overall structural flex-
ibility (65). As the flexibility of the protein increases, the
hinge between the top and bottom regions of the NMDAR
LBD becomes looser, and the protein moves to an overall
more open conformation and therefore lower FRET states.
The recovery of the FRET states with reduced denaturant
concentration suggests that the structural change is revers-ible. When the hinge region is partially unfolded, the pro-
tein’s equilibrium would shift toward the open-cleft lower
FRET states with the two arms well separated. When the
hinge region reforms, the protein can stiffen again and
fold back to the base structure. This model is consistent
with our results, but could potentially relate to the functional
issue of LBD activation and/or desensitization. Further work
is required to elucidate any possible relationship.CONCLUSIONS
We have shown that the glycine-saturated LBD of the
GluN1 subunit of the NMDAR has a complex conforma-
tional landscape. Using smFRET, we were able to measure
and locate conformational states that the protein adopts on a
timescale of the order of milliseconds to seconds. Intro-
ducing increasing concentrations of denaturant shifts the
protein’s equilibrium toward open conformations and is a
reversible process. The denaturant-induced shift toward
open conformations maintains reversibility, which supports
the notion that we are observing equilibrium folding/unfold-
ing transitions. The protein moves primarily from adjacent
states and can migrate to both more open conformations
and more closed conformations similarly, matching both
theoretical calculations as well as a simple model of open-
ing and closing of the binding cleft. The most probable
transitions are consistent with cleft distances related to
the opening/closing transitions in the full protein. These
findings can be helpful in further studies to address the
complex functionalities of the NMDAR LBD and have a
possible impact on drug design for treating NMDAR-related
diseases.SUPPORTING MATERIAL
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